Home/Filings/4/0001213900-22-080969
4//SEC Filing

Grove Janet P 4

Accession 0001213900-22-080969

CIK 0001728328other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:54 PM ET

Size

5.6 KB

Accession

0001213900-22-080969

Insider Transaction Report

Form 4
Period: 2022-12-16
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-12-16+8401,400 total
    Exercise: $1.78Exp: 2027-12-15Common shares (840 underlying)
Footnotes (2)
  • [F1]The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner.
  • [F2]On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001355675

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:54 PM ET
Size
5.6 KB